Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Changing profile of rotavirus genotypes in Bangladesh, 2006–2012

Authors: Mokibul Hassan Afrad, Zahid Hassan, Saiada Farjana, Sayra Moni, Subarna Barua, Sumon Kumar Das, Abu Syed Golam Faruque, Tasnim Azim, Mustafizur Rahman

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Rotavirus is the leading cause of severe diarrhea in infants and young children worldwide including Bangladesh. Unlike what was seen in high-income countries, the licensed rotavirus vaccines did not show high efficacy in Bangladeshi trials. We assessed rotavirus prevalence and genotypes in Bangladesh over six-year period to provide baseline information on the rotavirus burden and changing profile in the country.

Methods

This study was conducted from June 2006 to May 2012 in Matlab, Bangladesh. Group A rotaviruses were detected in stools collected from diarrhea patients by ELISA and genotyped using multiplex reverse transcription PCR followed by nucleotide sequencing.

Results

Of the 9678 stool samples, 20.3% were positive for rotavirus. The most predominant genotype was G1P[8] (22.4%), followed by G9P[8] (20.8%), G2P[4] (16.9%) and G12P[8] (10.4%). Mixed infections were detected in 14.2% of the samples. Emergence of an unusual strain, G9P[4] was documented during 2011–12. Several amino acid mismatches in the antigenic epitopes of VP7 and VP4 between Bangladeshi and the vaccine strains were identified.

Conclusions

Our study provides important information on rotavirus genotypes that should be considered for the selection and introduction of rotavirus vaccines in Bangladesh.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI: Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009, 200 (Suppl 1): S9-S15.CrossRefPubMed Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI: Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009, 200 (Suppl 1): S9-S15.CrossRefPubMed
2.
go back to reference Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD: Rotavirus vaccines: targeting the developing world. J Infect Dis. 2005, 192 (Suppl 1): S160-166.CrossRefPubMed Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD: Rotavirus vaccines: targeting the developing world. J Infect Dis. 2005, 192 (Suppl 1): S160-166.CrossRefPubMed
3.
go back to reference Estes M: Rotaviruses and their replication, 4th ed. edn. 2001, Philadelphia: Lippincott Williams & Wilkins Estes M: Rotaviruses and their replication, 4th ed. edn. 2001, Philadelphia: Lippincott Williams & Wilkins
4.
go back to reference Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Banyai K, Brister JR, Buesa J, Esona MD, Estes MK, Gentsch JR, et al: Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol. 2011, 156 (8): 1397-1413. 10.1007/s00705-011-1006-z.CrossRefPubMedPubMedCentral Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Banyai K, Brister JR, Buesa J, Esona MD, Estes MK, Gentsch JR, et al: Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol. 2011, 156 (8): 1397-1413. 10.1007/s00705-011-1006-z.CrossRefPubMedPubMedCentral
5.
go back to reference Trojnar E, Sachsenroder J, Twardziok S, Reetz J, Otto PH, Johne R: Identification of an avian group A rotavirus containing a novel VP4 gene with a close relationship to those of mammalian rotaviruses. J Gen Virol. 2013, 94 (Pt 1): 136-142.CrossRefPubMed Trojnar E, Sachsenroder J, Twardziok S, Reetz J, Otto PH, Johne R: Identification of an avian group A rotavirus containing a novel VP4 gene with a close relationship to those of mammalian rotaviruses. J Gen Virol. 2013, 94 (Pt 1): 136-142.CrossRefPubMed
6.
go back to reference Dunn SJ, Cross TL, Greenberg HB: Comparison of the rotavirus nonstructural protein NSP1 (NS53) from different species by sequence analysis and northern blot hybridization. Virology. 1994, 203 (1): 178-183. 10.1006/viro.1994.1471.CrossRefPubMed Dunn SJ, Cross TL, Greenberg HB: Comparison of the rotavirus nonstructural protein NSP1 (NS53) from different species by sequence analysis and northern blot hybridization. Virology. 1994, 203 (1): 178-183. 10.1006/viro.1994.1471.CrossRefPubMed
7.
go back to reference Dyall-Smith ML, Lazdins I, Tregear GW, Holmes IH: Location of the major antigenic sites involved in rotavirus serotype-specific neutralization. Proc Natl Acad Sci U S A. 1986, 83 (10): 3465-3468. 10.1073/pnas.83.10.3465.CrossRefPubMedPubMedCentral Dyall-Smith ML, Lazdins I, Tregear GW, Holmes IH: Location of the major antigenic sites involved in rotavirus serotype-specific neutralization. Proc Natl Acad Sci U S A. 1986, 83 (10): 3465-3468. 10.1073/pnas.83.10.3465.CrossRefPubMedPubMedCentral
8.
go back to reference Ward RL, Bernstein DI: Rotarix: a rotavirus vaccine for the world. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009, 48 (2): 222-228. 10.1086/595702.CrossRef Ward RL, Bernstein DI: Rotarix: a rotavirus vaccine for the world. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009, 48 (2): 222-228. 10.1086/595702.CrossRef
9.
go back to reference Linhares AC, Velazquez FR, Perez-Schael I, Saez-Llorens X, Abate H, Espinoza F, Lopez P, Macias-Parra M, Ortega-Barria E, Rivera-Medina DM, et al: Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008, 371 (9619): 1181-1189. 10.1016/S0140-6736(08)60524-3.CrossRefPubMed Linhares AC, Velazquez FR, Perez-Schael I, Saez-Llorens X, Abate H, Espinoza F, Lopez P, Macias-Parra M, Ortega-Barria E, Rivera-Medina DM, et al: Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008, 371 (9619): 1181-1189. 10.1016/S0140-6736(08)60524-3.CrossRefPubMed
10.
go back to reference Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al: Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006, 354 (1): 11-22. 10.1056/NEJMoa052434.CrossRefPubMed Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al: Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006, 354 (1): 11-22. 10.1056/NEJMoa052434.CrossRefPubMed
11.
go back to reference Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A: Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007, 370 (9601): 1757-1763. 10.1016/S0140-6736(07)61744-9.CrossRefPubMed Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A: Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007, 370 (9601): 1757-1763. 10.1016/S0140-6736(07)61744-9.CrossRefPubMed
12.
go back to reference Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al: Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006, 354 (1): 23-33. 10.1056/NEJMoa052664.CrossRefPubMed Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al: Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006, 354 (1): 23-33. 10.1056/NEJMoa052664.CrossRefPubMed
13.
go back to reference Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, et al: Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010, 376 (9741): 615-623. 10.1016/S0140-6736(10)60755-6.CrossRefPubMed Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, et al: Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010, 376 (9741): 615-623. 10.1016/S0140-6736(10)60755-6.CrossRefPubMed
15.
go back to reference Taneja DK, Malik A: Burden of rotavirus in India - Is rotavirus vaccine an answer to it?. Indian J Publ health. 2012, 56: 17-21. 10.4103/0019-557X.96951.CrossRef Taneja DK, Malik A: Burden of rotavirus in India - Is rotavirus vaccine an answer to it?. Indian J Publ health. 2012, 56: 17-21. 10.4103/0019-557X.96951.CrossRef
16.
go back to reference Narang A, Bose A, Pandit AN, Dutta P, Kang G, Bhattacharya SK, Datta SK, Suryakiran PV, Delem A, Han HH, et al: Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants. Human vaccines. 2009, 5 (6): 414-419.CrossRefPubMed Narang A, Bose A, Pandit AN, Dutta P, Kang G, Bhattacharya SK, Datta SK, Suryakiran PV, Delem A, Han HH, et al: Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants. Human vaccines. 2009, 5 (6): 414-419.CrossRefPubMed
17.
go back to reference Hoshino Y, Jones RW, Ross J, Honma S, Santos N, Gentsch JR, Kapikian AZ: Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J Virol. 2004, 78 (14): 7795-7802. 10.1128/JVI.78.14.7795-7802.2004.CrossRefPubMedPubMedCentral Hoshino Y, Jones RW, Ross J, Honma S, Santos N, Gentsch JR, Kapikian AZ: Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J Virol. 2004, 78 (14): 7795-7802. 10.1128/JVI.78.14.7795-7802.2004.CrossRefPubMedPubMedCentral
18.
go back to reference Estes MK: Rotaviruses and their replication. In., 4th edn. 2001, Philadelphia: Lippincott Williams & Wilkins Estes MK: Rotaviruses and their replication. In., 4th edn. 2001, Philadelphia: Lippincott Williams & Wilkins
19.
go back to reference Rahman M, Sultana R, Ahmed G, Nahar S, Hassan ZM, Saiada F, Podder G, Faruque AS, Siddique AK, Sack DA, et al: Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh. Emerg Infect Dis. 2007, 13 (1): 18-24. 10.3201/eid1301.060910.CrossRefPubMedPubMedCentral Rahman M, Sultana R, Ahmed G, Nahar S, Hassan ZM, Saiada F, Podder G, Faruque AS, Siddique AK, Sack DA, et al: Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh. Emerg Infect Dis. 2007, 13 (1): 18-24. 10.3201/eid1301.060910.CrossRefPubMedPubMedCentral
20.
go back to reference Herring AJ, Inglis NF, Ojeh CK, Snodgrass DR, Menzies JD: Rapid diagnosis of rotavirus infection by direct detection of viral nucleic acid in silver-stained polyacrylamide gels. J Clin Microbiol. 1982, 16 (3): 473-477.PubMedPubMedCentral Herring AJ, Inglis NF, Ojeh CK, Snodgrass DR, Menzies JD: Rapid diagnosis of rotavirus infection by direct detection of viral nucleic acid in silver-stained polyacrylamide gels. J Clin Microbiol. 1982, 16 (3): 473-477.PubMedPubMedCentral
21.
go back to reference Kobayashi N, Lintag IC, Urasawa T, Taniguchi K, Saniel MC, Urasawa S: Unusual human rotavirus strains having subgroup I specificity and "long" RNA electropherotype. Arch Virol. 1989, 109 (1–2): 11-23.CrossRefPubMed Kobayashi N, Lintag IC, Urasawa T, Taniguchi K, Saniel MC, Urasawa S: Unusual human rotavirus strains having subgroup I specificity and "long" RNA electropherotype. Arch Virol. 1989, 109 (1–2): 11-23.CrossRefPubMed
22.
go back to reference Kawai K, O'Brien MA, Goveia MG, Mast TC, El Khoury AC: Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review. Vaccine. 2012, 30 (7): 1244-1254. 10.1016/j.vaccine.2011.12.092.CrossRefPubMed Kawai K, O'Brien MA, Goveia MG, Mast TC, El Khoury AC: Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review. Vaccine. 2012, 30 (7): 1244-1254. 10.1016/j.vaccine.2011.12.092.CrossRefPubMed
23.
go back to reference Miles MG, Lewis KD, Kang G, Parashar UD, Steele AD: A systematic review of rotavirus strain diversity in India, Bangladesh, and Pakistan. Vaccine. 2012, 30 (Suppl 1): A131-139.CrossRefPubMed Miles MG, Lewis KD, Kang G, Parashar UD, Steele AD: A systematic review of rotavirus strain diversity in India, Bangladesh, and Pakistan. Vaccine. 2012, 30 (Suppl 1): A131-139.CrossRefPubMed
24.
go back to reference Unicomb LE, Podder G, Gentsch JR, Woods PA, Hasan KZ, Faruque AS, Albert MJ, Glass RI: Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J Clin Microbiol. 1999, 37 (6): 1885-1891.PubMedPubMedCentral Unicomb LE, Podder G, Gentsch JR, Woods PA, Hasan KZ, Faruque AS, Albert MJ, Glass RI: Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J Clin Microbiol. 1999, 37 (6): 1885-1891.PubMedPubMedCentral
25.
go back to reference Iturriza-Gomara M, Isherwood B, Desselberger U, Gray J: Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J Virol. 2001, 75 (8): 3696-3705. 10.1128/JVI.75.8.3696-3705.2001.CrossRefPubMedPubMedCentral Iturriza-Gomara M, Isherwood B, Desselberger U, Gray J: Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J Virol. 2001, 75 (8): 3696-3705. 10.1128/JVI.75.8.3696-3705.2001.CrossRefPubMedPubMedCentral
26.
go back to reference Zeller M, Rahman M, Heylen E, De Coster S, De Vos S, Arijs I, Novo L, Verstappen N, Van Ranst M, Matthijnssens J: Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine. 2010, 28 (47): 7507-7513. 10.1016/j.vaccine.2010.09.004.CrossRefPubMed Zeller M, Rahman M, Heylen E, De Coster S, De Vos S, Arijs I, Novo L, Verstappen N, Van Ranst M, Matthijnssens J: Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine. 2010, 28 (47): 7507-7513. 10.1016/j.vaccine.2010.09.004.CrossRefPubMed
27.
go back to reference Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, Cortese MM, Parashar UD, Glass RI, Bowen MD: United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J. 2011, 30 (1 Suppl): S42-47.CrossRefPubMed Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, Cortese MM, Parashar UD, Glass RI, Bowen MD: United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J. 2011, 30 (1 Suppl): S42-47.CrossRefPubMed
28.
go back to reference Jin Q, Ward RL, Knowlton DR, Gabbay YB, Linhares AC, Rappaport R, Woods PA, Glass RI, Gentsch JR: Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Arch Virol. 1996, 141 (11): 2057-2076. 10.1007/BF01718215.CrossRefPubMed Jin Q, Ward RL, Knowlton DR, Gabbay YB, Linhares AC, Rappaport R, Woods PA, Glass RI, Gentsch JR: Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Arch Virol. 1996, 141 (11): 2057-2076. 10.1007/BF01718215.CrossRefPubMed
29.
go back to reference Parashar UD, Glass RI: Rotavirus vaccines–early success, remaining questions. N Engl J Med. 2009, 360 (11): 1063-1065. 10.1056/NEJMp0810154.CrossRefPubMed Parashar UD, Glass RI: Rotavirus vaccines–early success, remaining questions. N Engl J Med. 2009, 360 (11): 1063-1065. 10.1056/NEJMp0810154.CrossRefPubMed
30.
go back to reference Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI: Oral rotavirus vaccines: how well will they work where they are needed most. J Infect Dis. 2009, 200 (Suppl 1): S39-48.CrossRefPubMedPubMedCentral Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI: Oral rotavirus vaccines: how well will they work where they are needed most. J Infect Dis. 2009, 200 (Suppl 1): S39-48.CrossRefPubMedPubMedCentral
Metadata
Title
Changing profile of rotavirus genotypes in Bangladesh, 2006–2012
Authors
Mokibul Hassan Afrad
Zahid Hassan
Saiada Farjana
Sayra Moni
Subarna Barua
Sumon Kumar Das
Abu Syed Golam Faruque
Tasnim Azim
Mustafizur Rahman
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-320

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.